Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
We recognize the impact animal health has on the health of people and the planet. Raising healthy animals limits potential for disease spread, supports livelihoods, and provides nutrient-rich meat, milk and eggs to nourish and support human health. We support prevention and control of disease as the increasingly preferred approach over disease treatment.
Our antibacterials, anticoccidials, vaccines, and other products improve animal health and make food safer by preventing and controlling disease. We’re also actively advancing the growing nutritional health segment of probiotics, prebiotics, and enzymes, working to offer producers broader options for protecting animal health and improving animal performance.
Elanco’s proven technologies ensure integrity of food supply, while our productivity enhancers make food affordable and available by helping raise animals more efficiently.
EPS and Sales:
|Date||EPS||% last year||% last quarter|
|Date||Sales||% last year||% last quarter|
Elanco Animal Health Completes Separation from Lilly
Are investors shorting Elanco Animal Health?
Elanco Animal Health saw a increase in short interest in February. As of February 28th, there was short interest totalling 54,173,571 shares, an increase of 54.1% from the February 15th total of 35,150,581 shares. Based on an average trading volume of 12,286,650 shares, the days-to-cover ratio is presently 4.4 days. Currently, 75.1% of the shares of the stock are short sold. View Elanco Animal Health’s Current Options Chain.
ZACKS ranked this stock C of value, growth and momentum